Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Non-Current Assets (2017 - 2025)

Entera Bio has reported Non-Current Assets over the past 9 years, most recently at $695000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets rose 66.27% year-over-year to $695000.0, compared with a TTM value of $695000.0 through Dec 2025, up 66.27%, and an annual FY2025 reading of $695000.0, up 66.27% over the prior year.
  • Non-Current Assets came in at $695000.0 for Q4 2025, up from $400000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.1 million in Q1 2021 to a low of $233000.0 in Q1 2023.
  • Median Non-Current Assets over the past 5 years was $498000.0 (2023), compared with a mean of $562850.0.
  • The sharpest move saw Non-Current Assets plummeted 65.35% in 2022, then surged 109.44% in 2024.
  • Over 5 years, Non-Current Assets stood at $658000.0 in 2021, then plummeted by 57.75% to $278000.0 in 2022, then surged by 82.73% to $508000.0 in 2023, then dropped by 17.72% to $418000.0 in 2024, then surged by 66.27% to $695000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Non-Current Assets are $695000.0 (Q4 2025), $400000.0 (Q3 2025), and $356000.0 (Q2 2025).